Sm_uary We established an in vitro cytokinesis-block micronucleus assay of human tumours for estimation of the proportion of cells undergoing mitosis (the dividing fraction, DF), the time for the number of nuclei to double and the radiosensitivity in terms of the micronucleus frequency, based on a concept described previously. Under certain conditions, the nuclear number doubling time (NNDT) Recently, the importance of an individualised approach to cancer therapy based on the biological characteristics of each patient's tumour has been increasingly stressed. In radiation therapy, the prediction of biological parameters such as the intrnsic radiosensitivity, proliferative activity (especially the potential doubling time: Tpo) and degree of hypoxia would be helpful in planning optimal treatment (Peters et al., 1988) . Several assay systems have been developed to estimate these parameters (Begg et al., 1988; Peters et al., 1988; Brock et al., 1989; H6ckel et al., 1993), but newer and better assays are needed because all of the existing ones have some disadvantages. In addition, none of the assays allows two or more parameters to be estimated simultaneously.
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In our previous studies using xenografted human and mouse tumours , we developed a new method of estimating tumour radiosensitivity and proliferative activity, which involved determining the micronucleus (MN) frequency after irradiation, the fraction of tumour cells undergoing mitosis in vitro (the dividing fraction, DF) and the presumed time for the number of tumour cell nuclei to double in vitro (nuclear number doubling time, NNDT). The NNDT is considered to be similar to Tpot provided that the culture conditions do not alter karyokinesis. This method makes use of the cytokinesisblock MN assay (Fenech & Morley, 1985) , in which tumours are disaggregated into single cells and cultured with or without irradiation for about a week in the presence of cytochalasin B to block cytoplasmic (but not nuclear) division. The MN frequency in binucleate cells (BNCs) was previously found to correlate with the surviving cell fraction in nine out of ten tumours investigated . The maximal percentage of multinucleate cells (MNCs) (= the DF) was found to correlate with the bromodeoxyuridine (BrdU) labelling index, and the NNDT generally corresponded to the Tpot estimated by the BrdU flow cytometry method .
As the next step in our studies, we have investigated the feasibility of performing this assay in various human tumours. We also investigated the correlation between assay data and clinical outcome. 
Assai procedure
The method used was similar to that of previous studies with slight modifications. The current standard procedure was performed as follows. Tumour specimens were minced with scissors and treated at 3TC for 2 h with 1 mg ml-' collagenase/dispase (Boehringer, Mannheim, Germany) dissolved in phosphate-buffered saline. Then the resulting tumour cell suspension was filtered through a fine wire mesh and viable cells were counted using trypan blue. The proportion of viable cells ranged from 25% to more than 90%, and the cell yield ranged between 1 x 106 and 7 x 10' per gram of tumour tissue. After removing the collagenase/dispase solution by centrifugation, the cells were plated into multiple collagen-coated dishes (20 cm2, Iwaki Glass, Tokyo Ltd., 1994 Br. J. Cancer (I 994), 70, 67 71 platg, cytochalasin B dissolved in dimethylsuiphoxide was added to all dishes. Various concentrations of cytochalasin B (0.5, 1, 1.5, 2, and 3 igml-') were added whenever the cell yield allowed it, but otherwise the drug was only added at 1.5 Lg ml-V'. The medium and cytochalasin B were both replaced when the culture duration was longer than 1 week.
Fixation and stainng Cultures were terminated at various intervals and the cells were fixed with 1% glutaraldehyde in phosphate buffer, treated with 5 N hydrochloric acid for 20 min and stained with Schiffis reagent for 1 h as described previously . When there was a sufficient number of culture dishes, unirradiated cells were fixed on a daily basis until day 5 and every other day thereafter until day 9-14. Irradiated cells were usually fixed on days 4-6 for high-grade tumours and on days 5, 7 and 9 for low-grade tumours. By monitoring the increase in BNCs in the unirradiated dishes, the best day for starting fixation of the irradiated cells was determined.
moto & Streffer, 1991). The NNDT was estimated by fitting the initial part of the nuclear ratio curve (i.e. the number of nuclei per cell) to an exponential curve and extrapolating it as shown in Figure 2 when necessary. This extrapolation was necessary for nearly all (52 of 58) tumours in which the nuclear ratio did not exceed 2.0. For curve fitting, all the points on the ascending portion were used; the data obtained on days 1-3 were used in almost all cases, while those obtained on day 4 or later were also used whenever appropriate. The fitted curve did not extrapolate through the origin in most cases, because some delay existed before mitosis commenced and because some tumours contained naturally mutlinucleate cells .
Tlhe assay data for all the tumours are shown in Tables I  and II . The DF ranged from 4.1% to 71% with a median of 21%, and the NNDT ranged from 3.1 to 83 days with a median of 9.8 days. The average number of micronuclei per binucleate cell at 2 Gy after subtraction of that at 0 Gy [MN/BNC (2 Gy-O Gy)] ranged from 0.052 (bladder cancer) to 0.35 (liver metastasis of pancreatic cancer) with a median of 0.12. Scoring and analysis Tumour cells were distinguished from normal cells on the basis of morphological criteria such as nuclear irregularity and a high nucleocytoplasmic ratio (Papanicolaou, 1954; Barker & Sanford, 1970) value. This was also found to be the case in our previous study of xenografted human and mure tumours (Shiba- Our previous study showed that the MN frequency in BNCs of both irradiated and unirradiated cultures inreased as the culture durrtion became longer in some tumours, but the present study only detected this phenomenon in two tumours in which cells with three or more nulcei became prevalent.
Correlation of the assay data with the clinical outcome Of the 58 evaluable patients, 33 underwent macroscopically curative tumour resection, excluding the patients with distant metastases. Two of the 17 patients whose tumours had a DF<20%, and six of the 16 patients whose tumours had a NNDT (days) DF .20% received post-operative radiation therapy. Figure  3 shows that a DF .20% was associated with a significantly higher recurrence rate (P = 0.00568 by the generalised Wilcoxon test). Six patients developed recurrence, and the interval between the previous surgery and relapse was also known in the 13 patients operated on for recurrence. Figure 4 shows a good correlation between the NNDT and the time to relapse in these 19 patients (R=0.921, P<0.001).
In 17 of the 29 patients who underwent radiation therapy, the response of the primary or metastatic lesions was evaluable. Figure 5 shows the correlation between the tumour response to radiotherapy and the MN frequency determined at 2 Gy (after subtraction of the value at 0 Gy). (Gatter et al., 1986; Garcia et al., 1989) , suggesting that investigation of the correlation between DF and the growth fraction is warranted. The DF was clearly higher in the more malignant tumours, and patients with tumours with a high DF had a worse prognosis. Thus, the DF appears to be a good index of degree of malignancy.
In this study, NNDT was used as an estimate of the Tpol. The conditions under which the NNDT represents the Tpot have been discussed previously .
Estimation of NNDT is more accurate for tumours in which the nuclear ratio exceeds 2.0, but this was the case in only six out of the 58 evaluable tumours. This may have been mainly because of environmental changes and poor adaptation of the tumour cells to culture as well as because of the suppression of nuclear division by cytochalasin B. When the nuclear ratio does not increase, the estimated NNDT will tend to be higher than the Tpt. When compared with Tpot data obtained by the BrdU flow cytometry technique, our NNDT values agreed well for meningioma (Riccardi et al., 1988) and lung cancer (Wilson et al., 1988) , but were slightly higher for head and neck cancer (Wilson et al., 1988; Begg et al., 1990 ) and bladder cancer (Begg et al., 1988) . In clinical radiotherapy, however, it is most important to detect the tumours with a short Tpot for which accelerated fractionation may be indicated, and the NNDT appears to be useful for this purpose. In addition, Figure 4 indicates that NNDT measurement is also useful in estimating post-treatment period with a high risk of recurrence. In countries such as Japan where BrdU cannot be legally given to patients, our method could provide a substitute for the BrdU method.
The production of micronuclei is considered to be linked to cell death (Joshi et al., 1982; Campbell & Warenius, 1989) and a correlation has been reported between the MN fre- (Wandl et al., 1989; . In such cases, the best parameter of radiation response is unknown. It may be argued that the MN frequency for all BNCs does not represent the radiosensitivity of a small proportion of clonogenic cells and hence may not predict the radiocurability of tumours. However, a correlation appeared to exist between the MN frequency after irradiation and the tumour response to radiotherapy in our 17 patients with measurable lesions. Further investigation in a larger group of patients and assessment of the correlation with local tumour control is now in progress.
As a predictive assay, our method has some advantages. Firstly, the influence of contamination by normal cells can be excluded. We distinguished tumour cells from normal cells under the microscope on the basis of morphological criteria (Papanicolaou, 1954; Barker & Sanford, 1970) . Although we used the central parts of the tumours for assay, normal cells appeared to be present in all of the specimens in varying proportions, and it was common for more than half of the cells to be non-tumour cells. In this respect, our assay is superior to other assays in which the inability to make such a distinction can lead to erroneous results.
The relative rapidity of our method when compared with clonogenic assays is also an advantage. In the case of malignant tumours, most of the important information was available within 5 days, which should allow the use of our method as a predictive assay in the clinical setting.
The main disadvantage of this assay is that a relatively large volume of tumour tissue is required (preferably > 300 mg). Therefore, a biopsy specinen is likely to be too small. For this reason, malignant brain tumours are a good possibility for further studies because most of them are irradiated after partial resection. Tumours which generally require post-operative radiation therapy would also be suitable for further investigation.
In summary, the cytokinesis-block MN assay can be used for human tumours and simultaneously provides data on the DF, NNDT and MN frequency. These parameters appear to be correlated with the treatment outcome of the patients. Further investigation of the assay seems to be fruitful.
